Stocks Grind Higher Into The Close; Tech Leads, VIX Slips
U.S. stocks edged up into the close with Technology and Consumer Cyclical leading, Utilities lagging, and dispersion elevated as Netflix–WBD dominated headlines.
U.S. stocks edged up into the close with Technology and Consumer Cyclical leading, Utilities lagging, and dispersion elevated as Netflix–WBD dominated headlines.
United enables 2X miles on rent through Bilt partnership, marking third non-travel collaboration in 60 days as ecosystem strategy accelerates.
Management cut FY2025 EBITDA guidance by $200M three weeks after dividend affirmation, forcing investors to recalibrate 2026 recovery expectations.
Paramount escalates WBD bid to $5B to outbid Netflix, forcing Comcast to confront balance sheet constraints vs strategic conviction. Year-end decision looms.
Broadridge's DLR platform processes $368 billion daily repo volumes, up 466% year-over-year, validating blockchain infrastructure strategy.
FDS secures AWS integration deal six weeks after margin pressure raised investor doubts about AI infrastructure spending returns.
Cooper Companies announced a strategic review 19 days after Jana Partners' campaign, appointing a new Board Chair with divestiture expertise.
FDA grants fifth U.S. indication with 95.5% response rate, reinforcing oncology execution one day after neuroscience trial setback disclosure.
U.S. equities ended mixed as investors await PCE inflation and the Fed. Tech leadership persists but is fractured; retail bifurcation and energy resilience stand out.
Stocks trade mixed at midday as utilities and energy outperform; jobless claims fall to a three-year low and margin debt hits a record, sharpening risk controls.
Stocks closed higher with the Dow up 408 points as cyclicals led and mega-cap tech lagged. Jobs data and Fed expectations loom before the bell.
Stocks advanced into the close as the Dow rose +0.86% and the S\&P 500 added +0.30%, with Energy, Financials, and Industrials leading while VIX fell to 16.08.
National Grid deploys AI wildfire risk platform across US and UK networks, testing operational governance credibility in wake of Heathrow crisis.
Site execution issues delay Alzheimer's psychosis readout to 2026, but trial continuation preserves Karuna acquisition optionality and neuroscience strategy.
U.S. stocks closed higher Tuesday as AI-led tech and industrials rallied; overnight, futures firmed ahead of ADP payrolls and global central bank cues.
U.S. stocks climbed into the close Tuesday, led by semis and select industrials, while volatility eased and energy lagged into the bell.
U.S. stocks edge higher at midday as semis and travel rally; VIX slides. Consumer staples, energy, and materials lag while Boeing, Intel, and MongoDB surge.
Goldman upgrade to $145 follows Q3 profit reversal and Macau's strongest monthly revenue since 2019, contradicting prior bearish thesis.
Wabtec finalizes €675 million Frauscher acquisition as promised, validating M\&A execution credibility and beginning three-year synergy realization timeline.
U.S. stocks closed lower Monday with volatility mixed and dispersion elevated. Overnight macro and AI headlines set the tone for a choppy Tuesday open.
MetLife closes $10B variable annuity risk transfer with Talcott, freeing capital for institutional retirement income expansion following Alight partnership.
Sponsor's $175M secondary offering at 18% discount triggered 35% price collapse. Institutional buyers caught underwater as valuation premium evaporates.
Unsolicited $1.6B all-stock bid forces board to weigh 30% premium against standalone recovery prospects amid bedding volume crisis and debt pressures.
Mali's $430M settlement and North American IPO study validate Elliott's separation thesis within two weeks, compressing expected timelines.
First Actuarial deal extends M\&A surge to UK pensions market, testing management's multi-regional execution capacity.
Federal judge allows breach-of-contract claims over delayed Breyanzi approval while December ASH presentations showcase next-generation hematology assets.
U.S. stocks faded into Monday’s close as volatility climbed and energy, utilities, and healthcare diverged sharply. Traders refocused on BOJ risks and ISM data.
Stocks extended an afternoon bid into the close, led by energy and defensives, while tech rallied on breadth even as Nvidia lagged. Volatility fell sharply.
Stocks grind higher into midday as Energy leads, volatility falls, and the CME outage fades from view. Tech diverges with INTC surging and NVDA lagging.
Comcast formally bid for Warner Bros. Discovery despite analyst warnings that Trump DOJ will block the deal. Board decision expected by year-end.
Q3 earnings and Investor Day disclose pro-forma RemainCo metrics, confirming March 2026 separation timeline amid Wind River impairment and trade headwinds.
Nov 6 call confirms HB 4384 delivered $0.12 benefit, unveils $26B capex through 2030, formalizes 6-8% EPS and dividend growth policy.
Black Friday open faces CME outage fallout. U.S. indices closed higher Thursday as cyclicals led; watch AI geopolitics, Europe data, and retail headlines today.
Stocks rose into the close Friday as energy, materials, and utilities outperformed while mega-cap tech steadied leadership. Volatility stayed contained.
Four major analyst upgrades and all-time high stock price confirm market repricing of Welltower's $23B seniors housing transformation program.
European Commission grants fourth Breyanzi indication with 82.7% response rate, reinforcing oncology execution despite pipeline challenges.
Stocks extended gains into Thanksgiving week as rate-cut hopes, AI infrastructure demand and crypto strength shaped risk appetite. Here’s what to watch.
U.S. stocks rose for a fourth session into the close, led by energy and staples, while the VIX fell to 17.19. Tech hardware rallied into the bell as software lagged.
Lo Li from Capital One joins Truist to lead consumer banking technology, signaling parallel execution on both wholesale and consumer expansion pillars of 2027.
Post-earnings momentum and 10th consecutive quarterly raise validate dividend sustainability despite Q3 consensus miss; valuation enters compelling territory.
Q3 2025 earnings show margin resilience amid bedding demand weakness, leaving recovery dependent on demand inflection rather than cost discipline.
Clorox beat Q1 estimates despite 19% sales decline; ERP transition transient, pricing power validated, insider buying signals conviction.
BSX Q3 margins expanded 60-80 bps driven by FARAPULSE-OPAL integration and WATCHMAN momentum, offsetting tariffs.
Q3 beat and guidance raise validate execution. Direct sales +85%, ACC migrations accelerate, AI monetization framework emerges.
Political attack on $42B mandate converges with credit fraud probe, testing BlackRock's institutional credibility amid portfolio stress.
U.S. equities advance into midday with Energy, Staples, and Materials leading while volatility retreats; Fed uncertainty and mixed data keep tone selective.
Stocks extended gains Tuesday as cyclicals led and volatility eased. Overnight headlines on TPUs, tariffs, and rate-cut odds set up today’s open.
Equities built on midday gains into the close as volatility fell. Cyclicals led while semis split, with NVDA and AMD lower even as ADI and AMAT climbed.
Stocks extend early gains into midday as cyclicals lead, semis lag, and volatility eases. We unpack rotation, Fed cut odds, and key movers with verified data.
Truist raises target to $240, JPMorgan to $230 post-Q3 earnings. Consensus reprices +9.8% to $229.69 as institutional conviction solidifies around bull-case.